BIO logo

BIO R&D to Revenue

Latest reported9.40%
BIO Quarterly R&D/Revenue (0.00% → 9.40%)
High-resolution chart · PNG

BIO r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock R&D to Revenue — Quarterly
Period endingR&D to Revenue
9.061%
9.0927%
9.0245%
9.4045%
9.3902%
9.7291%
9.6708%
9.6916%
9.4128%
8.3532%
8.9226%
10.303%
9.8239%
8.5198%
11.3126%
11.0553%
10.586%
10.1983%
9.2982%
10.0414%
9.6%
8.8643%
8.6191%
9.1496%
8.6823%
8.5802%
8.5832%
8.7112%
8.5781%
8.1382%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.